Verici Dx plc (LON:VRCI – Get Free Report)’s share price dropped 10.3% during mid-day trading on Thursday . The company traded as low as GBX 3.23 ($0.04) and last traded at GBX 3.25 ($0.04). Approximately 638,508 shares traded hands during trading, a decline of 14% from the average daily volume of 741,081 shares. The stock had previously closed at GBX 3.63 ($0.05).
Verici Dx Stock Up 7.7 %
The firm has a market capitalization of £10.62 million, a price-to-earnings ratio of -2.03 and a beta of 1.59. The business’s 50-day moving average is GBX 3.65 and its two-hundred day moving average is GBX 4.77. The company has a debt-to-equity ratio of 4.64, a quick ratio of 8.49 and a current ratio of 4.54.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- When to Sell a Stock for Profit or Loss
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- 3 Stocks to Consider Buying in October
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
- Insider Trades May Not Tell You What You Think
- MarketBeat Week in Review – 02/10 – 02/14
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
